StonvexLoading…
StonvexStonvexStonvexCore line items from TPET's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-01-31 | Annual 2025 2025-10-31 | Q3 2025 2025-07-31 | Q2 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $122.19K | $398.73K | $226.49K | $34.09K |
Operating Income | $-804.39K | $-5.27M | $-2.76M | $-2.09M |
Net Income | $-1.01M | $-7.28M | $-4.57M | $-1.56M |
EPS (Diluted) | $-0.10 | $-0.80 | $-0.69 | $-0.53 |
Total Assets | $14.17M | $13.21M | $13.03M | $13.77M |
Total Liabilities | $1.97M | $1.91M | $1.61M | $2.32M |
Cash & Equivalents | $684.65K | $882.16K | $584.37K | $1.46M |
Free Cash Flow OCF − CapEx | $-588.99K | Not available | Not available | Not available |
Shares Outstanding | 12.77M | 9.05M | 8.40M | 7.50M |